butorphanol + ropivacaine

Butorphanol + ropivacaine is a combination of two pharmaceutical agents used primarily for regional anesthesia and pain management, especially in perioperative and obstetric settings. Butorphanol is a synthetic opioid agonist-antagonist analgesic that acts as a partial agonist at the kappa-type opioid receptor and as an antagonist or partial agonist at the mu-type opioid receptor, providing analgesia with reduced risk of certain opioid side effects. Ropivacaine is an amide-type local anesthetic that blocks sodium channels on nerve fibers, inhibiting nerve impulse conduction to produce local or regional anesthesia. When combined, butorphanol enhances the sensory block duration and improves postoperative pain control compared to ropivacaine alone, while also reducing overall opioid consumption postoperatively[1][5]. This combination is commonly used in epidural or peripheral nerve block techniques for labor analgesia and postoperative pain management.